Table 1.
Variable | Summary |
---|---|
Complications | 18/117 (15%) |
Median LOS in days | 1 (IQR: 1–2) |
LOS >1 day | 36/117 (32%) |
Median duration with catheter in days | 1 (IQR: 1–2) |
Catheter >5 days | 10/76 (13%) |
Median energy in J | 67,637 (IQR: 28,785–109,813) |
Energy >100,000J | 32/116 (28%) |
Median preoperative PSA in ng/ml | 3.2 (IQR: 1.6–6.8) |
Postoperative PSA >5ng/ml | 29/78 (37%) |
Median postoperative PSA in ng/ml | 4.3 (IQR: 2.0–8.2) |
Postoperative PSA >5ng/ml | 15/41 (37%) |
Median preoperative Qmax in ml/s (n=11) | 9.3 (IQR: 6.0–10.6) |
Median postoperative Qmax in ml/s (n=18) | 13.5 (IQR: 9.1–16.2) |
LOS = length of stay; IQR = interquartile range; PSA = prostate specific antigen; Qmax = maximum flow rate